pharmacie et médicaments – Réduction des remises sur les génériques

This written question concerns the reduction of rebates on generic medicines in France. It seeks clarification on the potential impact of such reductions on the pharmaceutical market and patient access to affordable treatments. The question addresses the pharmaceutical industry and healthcare providers. It aims to understand the implications for drug pricing, competition, and the overall cost of healthcare for citizens.